Escalon Medical Corp. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported revenue was USD 2.7 million compared to USD 2.9 million a year ago. Net loss was USD 0.053154 million compared to net income of USD 0.098476 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.
For the six months, revenue was USD 5.38 million compared to USD 5.31 million a year ago. Net income was USD 0.264066 million compared to net loss of USD 0.098077 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.02 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to diluted loss per share from continuing operations of USD 0.02 a year ago.